Is exercise financing worth it?

It can be, if exercising is the right move but you lack the cash and you believe in the upside — you're paying a premium for someone else to carry the downside risk. But the provider's share of the gain can be large, so run the actual exercise cost first and compare it against alternatives like selling a slice of your shares.

Is selling some shares cheaper than financing an exercise?

Often, if your shares are vested and transferable. Selling a portion in a secondary at an agreed price to fund the exercise and tax on the rest can be cheaper than giving a financier an open-ended share of your whole upside. It depends on your company's transfer rules (right of first refusal, board approval), so check those first.

Exercising options · US

Non-recourse financing to exercise stock options — how it works, and when selling a slice is smarter

Q: What is non-recourse financing for exercising stock options?

It's an arrangement where a provider gives you the cash to exercise your options (and sometimes to pay the tax), in exchange for a share of the future upside on those shares. 'Non-recourse' means that if the shares become worthless, you don't have to repay the money — the provider absorbs the loss, which is why the cost is high.

If exercising is the right move but you don’t have the cash, a financing provider can front the cost — for a share of your upside. Here’s how it works, what it really costs, and the alternative most people don’t consider.

Exercising options isn’t free: you pay the strike price, and often a tax bill on top, potentially years before the shares are liquid. When that cash isn’t there, non-recourse exercise financing is one way through — but it’s not the only one, and it’s not cheap.

What “non-recourse” means

A financing provider gives you the money to exercise (and sometimes to cover the tax). In exchange, they take a share of the future upside on those shares. Non-recourse is the key feature: if the shares end up worthless, you don’t owe the money back — the provider takes the loss. That downside protection is exactly why the cost is high.

What it really costs

A share of the gain. Providers typically take a meaningful slice of the upside (plus, sometimes, a fee or interest). On a big outcome, that share can be a large absolute number.
You give up flexibility. The arrangement is tied to those shares until a liquidity event, on the provider’s terms.
It only makes sense if you believe in the upside — you’re paying a premium for someone else to carry the downside.

Do the maths first. Before financing anything, know the actual cost to exercise — strike plus tax. Our free ISO/AMT calculator gives you that number in seconds, so you can judge whether financing (and its cost) is even worth it.

The alternative most people miss: sell a slice

If your shares are already vested and transferable, you may be able to sell a portion in a secondary to a private buyer and use the proceeds to fund the exercise and tax on the rest — keeping the remainder without giving a financier a cut of your whole upside. It depends on your company’s transfer rules (right of first refusal, board approval), but where it’s possible it can be cheaper than financing, because you’re selling at a price you agree rather than paying an open-ended share of the gain.

You can list shares privately here — you stay anonymous until an investor signs an NDA, and only pay if a deal closes.

Established financing providers (independent)

If financing is the right route, these US providers fund option exercises. We’re not affiliated and earn nothing from these links — compare terms carefully.

Secfi, EquityBee, ESO Fund — exercise / tax financing (terms vary).

Non-recourse financing to exercise stock options — how it works, and when selling a slice is smarter

What “non-recourse” means

What it really costs

The alternative most people miss: sell a slice

Established financing providers (independent)

Read next

Free: the Equity Starter Kit

Further reading